During the past decade, The Affiliated Hospital to Changchun University of Chinese Medicine conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Affiliated Hospital to Changchun University of Chinese Medicine" #1 sponsor was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 8 trials, followed by "China Academy of Chinese Medical Sciences" with 3 trials sponsored, "Changchun University of Chinese Medicine" with 2 trials sponsored, "Liaoning University of Traditional Chinese Medicine" with 2 trials sponsored and "Anhui Palo Alto Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Affiliated Hospital to Changchun University of Chinese Medicine" #1 collaborator was "China Food and Drug Administration" with 2 trials as a collaborator, "Hengyang Traditional Chinese Medicine Hospital" with 2 trials as a collaborator, "Jilin University" with 2 trials as a collaborator, "Qilu Hospital of Shandong University" with 2 trials as a collaborator and "Second People's Hospital of Hunan" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "The Affiliated Hospital to Changchun University of Chinese Medicine" are "Stable Angina Pectoris" (2 trials), "Type 2 Diabetes" (2 trials), "Advanced Cervical Cancer" (1 trials), "Allergic Rhinitis" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "The Affiliated Hospital to Changchun University of Chinese Medicine" in a lesser frequency.

Most popular intervention types in "The Affiliated Hospital to Changchun University of Chinese Medicine" are "Drug" (21 trials), "Other" (4 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Danhong injection" (2 trials), "Standard medical care" (2 trials), "acupuncture" (2 trials) and "Aspirin Enteric-coated Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Affiliated Hospital to Changchun University of Chinese Medicine" are 22 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Affiliated Hospital to Changchun University of Chinese Medicine". 2 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in The Affiliated Hospital to Changchun University of Chinese Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Affiliated Hospital to Changchun University of Chinese Medicine, 8 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".